| Julie M Warnecke, NP | |
|
141 W 22nd St Ste 109, Anderson, IN 46016-4315 | |
| (765) 646-8538 | |
| Not Available |
| Full Name | Julie M Warnecke |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 9 Years |
| Location | 141 W 22nd St Ste 109, Anderson, Indiana |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003351339 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363L00000X | Nurse Practitioner | 71006775A (Indiana) | Secondary |
| 363LF0000X | Nurse Practitioner - Family | 71006775A (Indiana) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Ascension St Vincent Anderson | Anderson, IN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| St Vincent Medical Group Inc | 7012047640 | 625 |
News Archive
Women with migraine have a 50% increased risk of major cardiovascular disease, suggests a cohort study of Nurses' Health Study II participants.
Osteologix, Inc. (OTCBB:OLGX) today announced that the Japan Patent Office (JPO) has issued a Decision to Grant a Patent for Application Number 2006-504379: "Treating Cartilage/Bone Conditions with Water-Soluble Strontium Salts". The patent claims cover the treatment of osteoporosis and related bone conditions using NB S101 (strontium malonate), the Company's lead osteoporosis drug candidate.
The WHO said on Thursday that it was aiming for 'complete control' by 2015 of tropical diseases that affect one billion impoverished people and kill an estimated 534,000 people each year, Agence France-Presse reports.
Extensive statistical analyses of the mutation distribution in several thousand cancerous tumours make it possible to find cures for types of cancer that cannot be treated today.
Antithrombotic therapy using antiplatelet and anticoagulant agents is the cornerstone of treatment for acute and chronic coronary artery disease (CAD), yet it is also associated with an increased risk of bleeding. It is paradoxical that elderly patients, the most likely population to develop CAD, are those that suffer most from bleeding complications.
› Verified 9 days ago
| Entity Name | Indiana University Health Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1376586719 PECOS PAC ID: 2365350675 Enrollment ID: O20040407000695 |
News Archive
Women with migraine have a 50% increased risk of major cardiovascular disease, suggests a cohort study of Nurses' Health Study II participants.
Osteologix, Inc. (OTCBB:OLGX) today announced that the Japan Patent Office (JPO) has issued a Decision to Grant a Patent for Application Number 2006-504379: "Treating Cartilage/Bone Conditions with Water-Soluble Strontium Salts". The patent claims cover the treatment of osteoporosis and related bone conditions using NB S101 (strontium malonate), the Company's lead osteoporosis drug candidate.
The WHO said on Thursday that it was aiming for 'complete control' by 2015 of tropical diseases that affect one billion impoverished people and kill an estimated 534,000 people each year, Agence France-Presse reports.
Extensive statistical analyses of the mutation distribution in several thousand cancerous tumours make it possible to find cures for types of cancer that cannot be treated today.
Antithrombotic therapy using antiplatelet and anticoagulant agents is the cornerstone of treatment for acute and chronic coronary artery disease (CAD), yet it is also associated with an increased risk of bleeding. It is paradoxical that elderly patients, the most likely population to develop CAD, are those that suffer most from bleeding complications.
› Verified 9 days ago
| Entity Name | Indiana University Health Care Associates Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1902032832 PECOS PAC ID: 5799755864 Enrollment ID: O20040727000955 |
News Archive
Women with migraine have a 50% increased risk of major cardiovascular disease, suggests a cohort study of Nurses' Health Study II participants.
Osteologix, Inc. (OTCBB:OLGX) today announced that the Japan Patent Office (JPO) has issued a Decision to Grant a Patent for Application Number 2006-504379: "Treating Cartilage/Bone Conditions with Water-Soluble Strontium Salts". The patent claims cover the treatment of osteoporosis and related bone conditions using NB S101 (strontium malonate), the Company's lead osteoporosis drug candidate.
The WHO said on Thursday that it was aiming for 'complete control' by 2015 of tropical diseases that affect one billion impoverished people and kill an estimated 534,000 people each year, Agence France-Presse reports.
Extensive statistical analyses of the mutation distribution in several thousand cancerous tumours make it possible to find cures for types of cancer that cannot be treated today.
Antithrombotic therapy using antiplatelet and anticoagulant agents is the cornerstone of treatment for acute and chronic coronary artery disease (CAD), yet it is also associated with an increased risk of bleeding. It is paradoxical that elderly patients, the most likely population to develop CAD, are those that suffer most from bleeding complications.
› Verified 9 days ago
| Entity Name | St Vincent Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1144513375 PECOS PAC ID: 7012047640 Enrollment ID: O20100609000045 |
News Archive
Women with migraine have a 50% increased risk of major cardiovascular disease, suggests a cohort study of Nurses' Health Study II participants.
Osteologix, Inc. (OTCBB:OLGX) today announced that the Japan Patent Office (JPO) has issued a Decision to Grant a Patent for Application Number 2006-504379: "Treating Cartilage/Bone Conditions with Water-Soluble Strontium Salts". The patent claims cover the treatment of osteoporosis and related bone conditions using NB S101 (strontium malonate), the Company's lead osteoporosis drug candidate.
The WHO said on Thursday that it was aiming for 'complete control' by 2015 of tropical diseases that affect one billion impoverished people and kill an estimated 534,000 people each year, Agence France-Presse reports.
Extensive statistical analyses of the mutation distribution in several thousand cancerous tumours make it possible to find cures for types of cancer that cannot be treated today.
Antithrombotic therapy using antiplatelet and anticoagulant agents is the cornerstone of treatment for acute and chronic coronary artery disease (CAD), yet it is also associated with an increased risk of bleeding. It is paradoxical that elderly patients, the most likely population to develop CAD, are those that suffer most from bleeding complications.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Julie M Warnecke, NP 141 W 22nd St Ste 109, Anderson, IN 46016-4315 Ph: () - | Julie M Warnecke, NP 141 W 22nd St Ste 109, Anderson, IN 46016-4315 Ph: (765) 646-8538 |
News Archive
Women with migraine have a 50% increased risk of major cardiovascular disease, suggests a cohort study of Nurses' Health Study II participants.
Osteologix, Inc. (OTCBB:OLGX) today announced that the Japan Patent Office (JPO) has issued a Decision to Grant a Patent for Application Number 2006-504379: "Treating Cartilage/Bone Conditions with Water-Soluble Strontium Salts". The patent claims cover the treatment of osteoporosis and related bone conditions using NB S101 (strontium malonate), the Company's lead osteoporosis drug candidate.
The WHO said on Thursday that it was aiming for 'complete control' by 2015 of tropical diseases that affect one billion impoverished people and kill an estimated 534,000 people each year, Agence France-Presse reports.
Extensive statistical analyses of the mutation distribution in several thousand cancerous tumours make it possible to find cures for types of cancer that cannot be treated today.
Antithrombotic therapy using antiplatelet and anticoagulant agents is the cornerstone of treatment for acute and chronic coronary artery disease (CAD), yet it is also associated with an increased risk of bleeding. It is paradoxical that elderly patients, the most likely population to develop CAD, are those that suffer most from bleeding complications.
› Verified 9 days ago
Nora D Mitiche, NP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1030 S Scatterfield Rd, Anderson, IN 46012 Phone: 765-644-5025 Fax: 765-643-4534 | |
Mrs. Christina Lynn Bennett, CNM Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 1931 Brown St, Anderson, IN 46016 Phone: 765-646-8247 | |
Francisca Moura-souchet, NP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 1728 Williams Way E, Anderson, IN 46011 Phone: 765-617-8398 | |
Stephanie Sciaudone, FNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 215 W 19th St, Anderson, IN 46016 Phone: 765-393-3891 Fax: 765-393-3892 | |
Jessica D Bode, Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1130 Medical Arts Blvd Ste 250, Anderson, IN 46011 Phone: 765-298-4282 Fax: 765-298-4989 | |
Mrs. Theresa R Neff, RN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 2610 Enterprise Dr., Anderson, IN 46013 Phone: 765-683-4400 Fax: 765-642-7903 |